3 completed, 1 terminated. 2 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 1 | 1 | Terminated 1 |
| Phase 3 | 1 | Completed 1 |
Follow Interferon alpha 2a: new trials by email Literature Review of Interferon alpha 2a trials Research Report on Interferon alpha 2a
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rintatolimod, Celecoxib and Interferon Alpha 2b With Pembrolizumab For the Treatment of Patients With Metastatic or Unresectable Triple Negative Breast Cancer Biopsy, Biospecimen Collection, Celecoxib - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma | Phase 1 / Phase 2 | Terminated | Roswell Park Cancer Institute | 5 | 2024-02-16 | 2026-08-31 |
| Pharmacokinetics and Pharmacodynamics of Interferon Alpha 2A Interferon alpha 2a - Healthy | Completed | Azidus Brasil | 24 | 2009-03-01 | 2010-10-26 | |
| Evaluation of Birdshot Retine Choroidopathy Treatment by Either Steroid or Interferon alpha2a interferon alpha 2a, prednisone - Birdshot Chorioretinopathy, Cystoid Macular Edema | Phase 2 | Completed | Assistance Publique - Hôpitaux de Paris | 58 | 2007-09-01 | 2013-01-23 |
| Study of Treatment High Risk and/or Low Risk Acute Lymphoblastic leukémia(ALL) Adults Stage III interferon alpha 2a - Leukemia, Lymphocytic, Acute | Phase 3 | Completed | French Innovative Leukemia Organisation | 232 | 1994-09-01 | 2007-06-06 |
Birdshot Chorioretinopathy (1) · Macular Edema (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Triple Negative Breast Neoplasms (1)
Assistance Publique - Hôpitaux de Paris (1) · Azidus Brasil (1) · French Innovative Leukemia Organisation (1) · Roswell Park Cancer Institute (1)
France (2) · Brazil (1) · United States (1)
Alexandre Frederico, Doctor (1) · Ellis Levine, MD (1)
P01CA234212 (1)